|
BNIP3L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.626000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.161200E-01 |
| Normal-vs-Stage2 |
4.407000E-01 |
| Normal-vs-Stage3 |
7.619600E-02 |
| Normal-vs-Stage4 |
4.705000E-01 |
| Stage1-vs-Stage2 |
4.378000E-01 |
| Stage1-vs-Stage3 |
3.818300E-02 |
| Stage1-vs-Stage4 |
6.194000E-01 |
| Stage2-vs-Stage3 |
3.959000E-01 |
| Stage2-vs-Stage4 |
9.315000E-01 |
| Stage3-vs-Stage4 |
4.495600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.722800E-01 |
| Normal-vs-AfricanAmerican |
9.333600E-01 |
| Normal-vs-Asian |
5.190600E-01 |
| Caucasian-vs-AfricanAmerican |
4.215600E-01 |
| Caucasian-vs-Asian |
3.370800E-01 |
| AfricanAmerican-vs-Asian |
4.670800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.152000E-01 |
| Normal-vs-Female |
1.238040E-01 |
| Male-vs-Female |
1.187610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.616800E-01 |
| Normal-vs-Extreme_Weight |
7.608600E-01 |
| Normal-vs-Obese |
7.194200E-02 |
| Normal-vs-Extreme_Obese |
3.027000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.483400E-01 |
| Normal_Weight-vs-Obese |
1.318420E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.718200E-01 |
| Extreme_Weight-vs-Obese |
4.659700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.813800E-01 |
| Obese-vs-Extreme_Obese |
1.025200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.616600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.546000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.306600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.331600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.970400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.175400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.735200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.805000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.389800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.576220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.385800E-01 |
| Normal-VS-Type2 PRCC |
3.340800E-01 |
| Normal-VS-KIRP CIMP |
5.704200E-02 |
| Normal-VS-Unclassified PRCC |
3.629800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.738000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.678500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.619600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.065760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.852200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.409800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.820800E-01 |
| Normal-vs-N1 |
1.103990E-01 |
| Normal-vs-N2 |
1.397810E-01 |
| N0-vs-N1 |
1.362250E-01 |
| N0-vs-N2 |
4.410400E-01 |
| N1-vs-N2 |
9.967600E-01 |
|
|
